3 Einträge gefunden

1. Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia

   1. Schlenk, R F
   2. Frech, P
   3. Weber, D
   4. Brossart, P
   5. Horst, H-A
   6. Kraemer, D
   7. Held, G

   2017 - Forschungsinformationssystem des UKE
2. Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS)

   1. Mossner, M
   2. Jann, J-C
   3. Nowak, D
   4. Platzbecker, U
   5. Giagounidis, A
   6. Götze, K
   7. Letsch, A

   2016 - Forschungsinformationssystem des UKE
3. Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5)

   1. Schuler, E
   2. Giagounidis, A
   3. Haase, D
   4. Shirneshan, K
   5. Büsche, G
   6. Platzbecker, U
   7. Nolte, F

   2016 - Forschungsinformationssystem des UKE